Contact Details
List Of Outlets
News Articles
Advertising Examples
Related Links

Competitive Advantage

Higher omega-3 concentration and the technology used to extract the fish oil.
[ READ MORE ]

VIEW VIDEO IN HD (1080P)
HomeProduct InfoPURE O3 TechnologyEnquiries & News

Latest Stories

Omega3 and Prostate Cancer


Major media worldwide reported of a study that correlates higher blood levels of long chain omega-3 fatty acid concentration in the serum to an increased risk of prostate cancer. Is this true?
Read whole Story
Posted. 2013-07-18

Thoughts on "Too Much Fish Oil Might Boost Prostate Cancer Risk."


A recent headliner suggesting that fish oils could boost prostate cancer risk has stimulated understandable worries and questions from regular users of fish oil supplements and oily fish eaters.
Read whole Story
Posted. 2013-07-13

Prostate Cancer – A Fish Tale


Have you heard that fish oil supplements cause prostate cancer?
Read whole Story
Posted. 2013-07-12

Omega-3 Fatty Acids and Your Baby's Vision


Omega-3 fatty acids can benefit your baby's vision, taken both while in the womb and in your breastmilk. Find out how.
Read whole Story
Posted. 2013-02-10

Older Headlines

Why should you take a highly concentrated Omega-3?

READ STORY

Fish oils 'help slow age decline'

READ STORY

Fish oil may double benefits of exercise for elderly

READ STORY

Fishing for your Child's Future

READ STORY

New Proof: daily dose of fish oil does help keep your brain young

READ STORY

Which fish do we use for our Omega 3?

READ STORY

The Ageing Brain and Dementia

READ STORY

Fishy stories

READ STORY

Why we do not add Omega 6

READ STORY

Baby's first pill?

READ STORY

Competitive Advantage

READ STORY

Omega-3 Polyunsaturated Fatty Acids & Cardiovascular Diseases

STATE-OF-THE-ART PAPER

Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Diseases

Carl J. Lavie, MD¹, Richard V. Milani, MD¹, Mandeep R. Mehra, MD² and Hector O. Ventura, MD¹

Omega-3 polyunsaturated fatty acid (ω-3 PUFA) therapy continues to show great promise in primary and, particularly in secondary prevention of cardiovascular (CV) diseases. The most compelling evidence for CV benefits of ω-3 PUFA comes from 4 controlled trials of nearly 40 000 participants randomized to receive eicosapentaenoic acid (EPA) with or without docosahexaenoic acid (DHA) in studies of patients in primary prevention, after myocardial infarction, and most recently, with heart failure (HF). We discuss the evidence from retrospective epidemiologic studies and from large randomized controlled trials showing the benefits of ω-3 PUFA, specifically EPA and DHA, in primary and secondary CV prevention and provide insight into potential mechanisms of these observed benefits. The target EPA + DHA consumption should be at least 500mg/day for individuals without underlying overt CV disease and at least 800 to 1 000mg/day for individuals with known coronary heart disease and HF. Further studies are needed to determine optimal dosing and the relative ratio of DHA and EPA ω-3 PUFA that provides maximal cardio protection in those at risk of CV disease as well in the treatment of atherosclerotic, arrhythmic, and primary myocardial disorders.

Reprint requests and correspondence: Dr Carl J. Lavie, Cardiac Rehabilitation, Ochsner Medical Center, 1514 Jefferson Highway, New Orleans, Louisiana 70121-2483 (clavie@ochsner.org).

¹ Department of Cardiovascular Diseases, Ochsner Medical Center, New Orleans, Louisiana
² Division of Cardiovascular Diseases, University of Maryland School of Medicine, Baltimore, Maryland

Research Paper
Posted. 2011-10-07





PURE O3 OUTLETS
Greenways
Shop C9
Lifestyle Centre
Gateway
Hermanus
P. +27 (0)28 312 4499

SEE ALL OUTLETS  
Improves general health. **
** These statements have not been evaluated by the food and drug administration. This product is not intended to diagnose, cure or prevent disease. © PURE O3 and TIGME.COM